Purpose. To review records of 330 patients who underwent surgery for femoral neck fractures with or without preoperative anticoagulation therapy. Methods. Medical records of 235 women and 95 men aged 48 to 103 years (mean, 81.6; standard deviation [SD], 13.1) who underwent surgery for femoral neck fractures with or without preoperative anticoagulation therapy were reviewed. 30 patients were on warfarin, 105 on aspirin, 28 on clopidogrel, and 167 were controls. The latter 3 groups were combined as the non-warfarin group and compared with the warfarin group. Hospital mortality, time from admission to surgery, length of hospital stay, return to theatre, and postoperative complications (wound infection, deep vein thrombosis, and pulmonary embolism) were assessed. Results. The warfarin and control groups were significantly younger than the clopidogrel and aspirin groups (80.8 vs. 80.0 vs. 84.2 vs. 83.7 years, respectively, p<0.05). 81% of the patients underwent surgery within 48 hours of admission. The overall
mean time from admission to surgery was 1.8 days; it was longer in the warfarin than the aspirin, clopidogrel, and control groups (3.3 vs. 1.8 vs. 1.6 vs. 1.6 days, respectively, p<0.001). The mean length of hospital stay was 17.5 (SD, 9.6; range, 3-54) days. The overall hospital mortality was 3.9%; it was 6.7% in the warfarin group, 3.8% in the aspirin group, 3.6% in the clopidogrel group, and 3.6% in the control group (p=0.80). Four patients returned to theatre for surgery: one in the warfarin group for washout of a haematoma, 2 in the aspirin group for repositioning of a mal-fixation and for debridement of wound infection, and one in the control group for debridement of wound infection. The warfarin group did not differ significantly from non-warfarin group in terms of postoperative complication rate (6.7% vs. 2.7%, p=0.228) and the rate of return to theatre (3.3% vs. 1%, p=0.318). Conclusion. It is safe to continue aspirin and clopidogrel prior to surgical treatment for femoral neck fracture. The risk of delaying surgery outweighs the peri-operative bleeding risk.
introduction
Prophylactic anticoagulation therapy for heart failure and atrial fibrillation in elderly patients is common. 1, 2 In such patients undergoing surgery for femoral neck fracture, surgeons should decide whether to continue, modify, cease, bridge, or even reverse the anticoagulation therapy. Delayed surgical treatment is associated with increased one-year mortality and complication rates. [3] [4] [5] [6] [7] Nonetheless, anticoagulation therapy increases the peri-operative bleeding risk, [8] [9] [10] [11] and is a risk factor for elective total hip/knee replacement. 12, 13 There is no consensus on preoperative anticoagulation management in patients undergoing surgery for femoral neck fracture. 14, 15 In our unit dedicated for hip fractures, the protocols for patients on anticoagulants undergoing surgery for femoral neck fracture are to continue aspirin and clopidogrel but to cease warfarin. 16 For patients on warfarin, if thrombophilia or a mechanical valve is indicated, heparin is infused once the international normalised ratio (INR) is <2 and the patient is considered ready for surgery once the INR is <1.5. Heparin infusion is stopped 6 hours prior to surgery. For patients with atrial fibrillation, warfarin is stopped and the patient is considered ready for surgery when the INR is <1.5. This study reviewed records of 330 patients who underwent surgery for femoral neck fracture with or without preoperative anticoagulation therapy.
Materials and Methods
This study was approved by the Human Research Ethics Committee of our hospital. Medical records of 235 women and 95 men aged 48 to 103 years (mean, 81.6; standard deviation [SD], 13.1) who underwent surgery for femoral neck fracture by a consultant surgeon or registrars under the supervision of a consultant surgeon between November 2010 and October 2011 were reviewed. 30 patients were on warfarin, 105 on aspirin, 28 on clopidogrel, and 167 were controls. The latter 3 groups were combined as the non-warfarin group and compared with the warfarin group. Hospital mortality, time from admission to surgery, length of hospital stay, return to theatre, and postoperative complications (wound infection, deep vein thrombosis, and pulmonary embolism) were assessed. Groups were compared using the Chi-squared test, Kruskal-Wallis test, and Fisher's exact test as appropriate.
results
All groups were comparable in gender ratio (p=0.566). The warfarin and control groups were significantly younger than the clopidogrel and aspirin groups (80.8 vs. 80.0 vs. 84.2 vs. 83.7 years, respectively, p<0.05, Table) .
81% of the patients underwent surgery within 48 hours of admission. The overall mean time from admission to surgery was 1.8 days; it was longer in the warfarin than the aspirin, clopidogrel, and control groups (3.3 vs. 1.8 vs. 1.6 vs. 1.6 days, respectively, p<0.001). The mean length of hospital stay was 17.5 (SD, 9.6; range, 3-54) days.
The overall hospital mortality was 3.9% (n=13); it was 6.7% (n=2) in the warfarin group, 3.8% (n=4) in the aspirin group, 3.6% (n=1) in the clopidogrel group, and 3.6% (n=6) in the control group (p=0.80). In the warfarin group, causes of death were cardiac failure (n=1) and multi-organ failure (n=1). In the aspirin group, causes of death were aspiration pneumonia (n=1), multi-organ failure (n=1), acute respiratory distress (n=1), and subarachnoid bleeding Effects of anticoagulants on outcome of femoral neck fracture surgery 31 after a fall (n=1). In the clopidogrel group, the cause of death was fat embolus (n=1). In the control group, causes of death were aspiration pneumonia (n=4), bowel perforation (n=1), and cardiovascular accident (n=1).
Four patients returned to theatre for surgery: one in the warfarin group for wash-out of a haematoma, 2 in the aspirin group for re-positioning of a malfixation and for debridement of wound infection, and one in the control group for debridement of wound infection. The warfarin group did not differ significantly from the non-warfarin group in terms of postoperative complication rate (6.7% vs. 2.7%, p=0.228) and the rate of return to theatre (3.3% vs. 1%, p=0.318).
discussion
Anticoagulants decrease the peri-operative ischaemic and thrombo-embolic risks, but increase the risk of bleeding. Our study suggested that aspirin or clopidogrel had minimal impact on hospital mortality and postoperative complication rate, whereas the time from admission to surgery was longer in patients on warfarin.
The use of clopidogrel is reported to increase bleeding and complication rates. Compared with those not on clopidogrel, patients on clopidogrel had approximately 200 ml higher blood loss and had an increased complication rate. 11 Patients on clopidogrel had increased risks of bleeding and postoperative complications when undergoing surgery within 48 hours of admission, compared with those undergoing surgery after 48 hours of admission. 10 Nonetheless, confounders such as surgical approach, surgical technique, and operating time were not adjusted for. The increased blood loss was not only due to the use of clopidogrel. When clopidrogel was stopped preoperatively, 20% of high-risk patients experienced an acute coronary syndrome between postoperative days 4 and 8. 17 Delayed surgery is associated with one-year mortality in patients on clopidogrel with femoral neck fracture. 18 Early operative treatment according to the Scottish Intercollegiate Guidance Network guidelines is suggested. 19 The British Orthopaedic Association stresses the importance of early surgery for patients with hip fracture, and sets a maximum delay of 48 hours. 20 Compared with those not on warfarin, patients on warfarin have higher risks of postoperative wound infection after total hip/knee replacement. 12, 13, 21 In our study, the lack of significant differences between the 4 groups in terms of hospital mortality and complications may have been due to a type-II error; the number of patients was relatively small in the clopidogrel and warfarin groups. The mean patient age also differed significantly between groups, although it is unlikely to have been a source of confounding bias.
conclusion
It is safe to continue aspirin and clopidogrel prior to surgical treatment for femoral neck fracture. The risk of delaying surgery outweighs the peri-operative bleeding risk.
